img

Global Mono Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Mono Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Mono vaccines reduce the number of shots your child needs while protecting against only one serious diseases
The global Mono Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Mono Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Mono Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Mono Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Mono Vaccine include GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India and Biokangtai, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Mono Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Mono Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Mono Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Mono Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
By Application
Adults
Children
Sales by Region
North America
the United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Mono Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mono Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Mono Vaccine Definition
1.2 Market by Type
1.2.1 Global Mono Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Market Segment by Application
1.3.1 Global Mono Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Mono Vaccine Sales
2.1 Global Mono Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Mono Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Mono Vaccine Revenue by Region
2.3.1 Global Mono Vaccine Revenue by Region (2018-2024)
2.3.2 Global Mono Vaccine Revenue by Region (2024-2034)
2.4 Global Mono Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Mono Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Mono Vaccine Sales Quantity by Region
2.6.1 Global Mono Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Mono Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Mono Vaccine Sales Quantity by Manufacturers
3.1.1 Global Mono Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Mono Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Mono Vaccine Sales in 2022
3.2 Global Mono Vaccine Revenue by Manufacturers
3.2.1 Global Mono Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Mono Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Mono Vaccine Revenue in 2022
3.3 Global Mono Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Mono Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Mono Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Mono Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Mono Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Mono Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Mono Vaccine Sales Quantity by Type
4.1.1 Global Mono Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Mono Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Mono Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Mono Vaccine Revenue by Type
4.2.1 Global Mono Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Mono Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Mono Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Mono Vaccine Price by Type
4.3.1 Global Mono Vaccine Price by Type (2018-2024)
4.3.2 Global Mono Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Mono Vaccine Sales Quantity by Application
5.1.1 Global Mono Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Mono Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Mono Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Mono Vaccine Revenue by Application
5.2.1 Global Mono Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Mono Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Mono Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Mono Vaccine Price by Application
5.3.1 Global Mono Vaccine Price by Application (2018-2024)
5.3.2 Global Mono Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Mono Vaccine Sales by Company
6.1.1 North America Mono Vaccine Revenue by Company (2018-2024)
6.1.2 North America Mono Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Mono Vaccine Market Size by Type
6.2.1 North America Mono Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Mono Vaccine Revenue by Type (2018-2034)
6.3 North America Mono Vaccine Market Size by Application
6.3.1 North America Mono Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Mono Vaccine Revenue by Application (2018-2034)
6.4 North America Mono Vaccine Market Size by Country
6.4.1 North America Mono Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Mono Vaccine Revenue by Country (2018-2034)
6.4.3 North America Mono Vaccine Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Mono Vaccine Sales by Company
7.1.1 Europe Mono Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Mono Vaccine Revenue by Company (2018-2024)
7.2 Europe Mono Vaccine Market Size by Type
7.2.1 Europe Mono Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Mono Vaccine Revenue by Type (2018-2034)
7.3 Europe Mono Vaccine Market Size by Application
7.3.1 Europe Mono Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Mono Vaccine Revenue by Application (2018-2034)
7.4 Europe Mono Vaccine Market Size by Country
7.4.1 Europe Mono Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Mono Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Mono Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Mono Vaccine Sales by Company
8.1.1 China Mono Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Mono Vaccine Revenue by Company (2018-2024)
8.2 China Mono Vaccine Market Size by Type
8.2.1 China Mono Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Mono Vaccine Revenue by Type (2018-2034)
8.3 China Mono Vaccine Market Size by Application
8.3.1 China Mono Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Mono Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Mono Vaccine Sales by Company
9.1.1 APAC Mono Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Mono Vaccine Revenue by Company (2018-2024)
9.2 APAC Mono Vaccine Market Size by Type
9.2.1 APAC Mono Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Mono Vaccine Revenue by Type (2018-2034)
9.3 APAC Mono Vaccine Market Size by Application
9.3.1 APAC Mono Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Mono Vaccine Revenue by Application (2018-2034)
9.4 APAC Mono Vaccine Market Size by Region
9.4.1 APAC Mono Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Mono Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Mono Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Mono Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Mono Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Mono Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Mono Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Mono Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Mono Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Mono Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Mono Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Mono Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GSK Mono Vaccine Products and Services
11.1.5 GSK Mono Vaccine SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Information
11.2.2 Sanofi Pasteur Overview
11.2.3 Sanofi Pasteur Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Sanofi Pasteur Mono Vaccine Products and Services
11.2.5 Sanofi Pasteur Mono Vaccine SWOT Analysis
11.2.6 Sanofi Pasteur Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merck Mono Vaccine Products and Services
11.3.5 Merck Mono Vaccine SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Pfizer Mono Vaccine Products and Services
11.4.5 Pfizer Mono Vaccine SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 CNBG
11.5.1 CNBG Company Information
11.5.2 CNBG Overview
11.5.3 CNBG Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 CNBG Mono Vaccine Products and Services
11.5.5 CNBG Mono Vaccine SWOT Analysis
11.5.6 CNBG Recent Developments
11.6 Sanofi Pasteur MSD
11.6.1 Sanofi Pasteur MSD Company Information
11.6.2 Sanofi Pasteur MSD Overview
11.6.3 Sanofi Pasteur MSD Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Sanofi Pasteur MSD Mono Vaccine Products and Services
11.6.5 Sanofi Pasteur MSD Mono Vaccine SWOT Analysis
11.6.6 Sanofi Pasteur MSD Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Company Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Serum Institute of India Mono Vaccine Products and Services
11.7.5 Serum Institute of India Mono Vaccine SWOT Analysis
11.7.6 Serum Institute of India Recent Developments
11.8 Biokangtai
11.8.1 Biokangtai Company Information
11.8.2 Biokangtai Overview
11.8.3 Biokangtai Mono Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Biokangtai Mono Vaccine Products and Services
11.8.5 Biokangtai Mono Vaccine SWOT Analysis
11.8.6 Biokangtai Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Mono Vaccine Value Chain Analysis
12.2 Mono Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mono Vaccine Production Mode & Process
12.4 Mono Vaccine Sales and Marketing
12.4.1 Mono Vaccine Sales Channels
12.4.2 Mono Vaccine Distributors
12.5 Mono Vaccine Customers
13 Market Dynamics
13.1 Mono Vaccine Industry Trends
13.2 Mono Vaccine Market Drivers
13.3 Mono Vaccine Market Challenges
13.4 Mono Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Mono Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Meningococcal Vaccine
Table 3. Major Manufacturers of Japanese Encephalitis Vaccine
Table 4. Major Manufacturers of Yellow Fever Vaccine
Table 5. Major Manufacturers of Hepatitis Vaccine
Table 6. Major Manufacturers of Cholera Vaccine
Table 7. Major Manufacturers of Other
Table 8. Global Mono Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Mono Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Mono Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Mono Vaccine Revenue Market Share by Region (2018-2024)
Table 12. Global Mono Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Mono Vaccine Revenue Market Share by Region (2024-2034)
Table 14. Global Mono Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 15. Global Mono Vaccine Sales by Region (2018-2024) & (K Units)
Table 16. Global Mono Vaccine Sales Market Share by Region (2018-2024)
Table 17. Global Mono Vaccine Sales by Region (2024-2034) & (K Units)
Table 18. Global Mono Vaccine Sales Market Share by Region (2024-2034)
Table 19. Global Mono Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 20. Global Mono Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 21. Global Mono Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Mono Vaccine Revenue Share by Manufacturers (2018-2024)
Table 23. Global Mono Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 24. Global Key Players of Mono Vaccine, Industry Ranking, 2021 VS 2022
Table 25. Global Mono Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Mono Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mono Vaccine as of 2022)
Table 27. Global Key Manufacturers of Mono Vaccine, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Mono Vaccine, Product Offered and Application
Table 29. Global Key Manufacturers of Mono Vaccine, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Mono Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 32. Global Mono Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 33. Global Mono Vaccine Sales Quantity Share by Type (2018-2024)
Table 34. Global Mono Vaccine Sales Quantity Share by Type (2024-2034)
Table 35. Global Mono Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Mono Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Mono Vaccine Revenue Share by Type (2018-2024)
Table 38. Global Mono Vaccine Revenue Share by Type (2024-2034)
Table 39. Mono Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 40. Global Mono Vaccine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 41. Global Mono Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 42. Global Mono Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 43. Global Mono Vaccine Sales Quantity Share by Application (2018-2024)
Table 44. Global Mono Vaccine Sales Quantity Share by Application (2024-2034)
Table 45. Global Mono Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Mono Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Mono Vaccine Revenue Share by Application (2018-2024)
Table 48. Global Mono Vaccine Revenue Share by Application (2024-2034)
Table 49. Mono Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 50. Global Mono Vaccine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 51. North America Mono Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 52. North America Mono Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 53. North America Mono Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 54. North America Mono Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 55. North America Mono Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 56. North America Mono Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Mono Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 58. North America Mono Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 59. North America Mono Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 60. North America Mono Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Mono Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 62. North America Mono Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 63. North America Mono Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Mono Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 65. North America Mono Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 66. Europe Mono Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 67. Europe Mono Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 68. Europe Mono Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 69. Europe Mono Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 70. Europe Mono Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 71. Europe Mono Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Mono Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 73. Europe Mono Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 74. Europe Mono Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 75. Europe Mono Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Mono Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 77. Europe Mono Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 78. Europe Mono Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Mono Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 80. Europe Mono Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 81. China Mono Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 82. China Mono Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 83. China Mono Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 84. China Mono Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 85. China Mono Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 86. China Mono Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Mono Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 88. China Mono Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 89. China Mono Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 90. China Mono Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Mono Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 92. APAC Mono Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 93. APAC Mono Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 94. APAC Mono Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 95. APAC Mono Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 96. APAC Mono Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Mono Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 98. APAC Mono Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 99. APAC Mono Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 100. APAC Mono Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Mono Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 102. APAC Mono Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 103. APAC Mono Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Mono Vaccine Sales Quantity by Region (2018-2024) & (K Units)
Table 105. APAC Mono Vaccine Sales Quantity by Region (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Mono Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Mono Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Mono Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 113. Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 114. Middle East, Africa and Latin America Mono Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Mono Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Mono Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Mono Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 118. Middle East, Africa and Latin America Mono Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 120. Middle East, Africa and Latin America Mono Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 121. GSK Company Information
Table 122. GSK Description and Overview
Table 123. GSK Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 124. GSK Mono Vaccine Product and Services
Table 125. GSK Mono Vaccine SWOT Analysis
Table 126. GSK Recent Developments
Table 127. Sanofi Pasteur Company Information
Table 128. Sanofi Pasteur Description and Overview
Table 129. Sanofi Pasteur Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 130. Sanofi Pasteur Mono Vaccine Product and Services
Table 131. Sanofi Pasteur Mono Vaccine SWOT Analysis
Table 132. Sanofi Pasteur Recent Developments
Table 133. Merck Company Information
Table 134. Merck Description and Overview
Table 135. Merck Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 136. Merck Mono Vaccine Product and Services
Table 137. Merck Mono Vaccine SWOT Analysis
Table 138. Merck Recent Developments
Table 139. Pfizer Company Information
Table 140. Pfizer Description and Overview
Table 141. Pfizer Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 142. Pfizer Mono Vaccine Product and Services
Table 143. Pfizer Mono Vaccine SWOT Analysis
Table 144. Pfizer Recent Developments
Table 145. CNBG Company Information
Table 146. CNBG Description and Overview
Table 147. CNBG Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 148. CNBG Mono Vaccine Product and Services
Table 149. CNBG Mono Vaccine SWOT Analysis
Table 150. CNBG Recent Developments
Table 151. Sanofi Pasteur MSD Company Information
Table 152. Sanofi Pasteur MSD Description and Overview
Table 153. Sanofi Pasteur MSD Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 154. Sanofi Pasteur MSD Mono Vaccine Product and Services
Table 155. Sanofi Pasteur MSD Mono Vaccine SWOT Analysis
Table 156. Sanofi Pasteur MSD Recent Developments
Table 157. Serum Institute of India Company Information
Table 158. Serum Institute of India Description and Overview
Table 159. Serum Institute of India Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 160. Serum Institute of India Mono Vaccine Product and Services
Table 161. Serum Institute of India Mono Vaccine SWOT Analysis
Table 162. Serum Institute of India Recent Developments
Table 163. Biokangtai Company Information
Table 164. Biokangtai Description and Overview
Table 165. Biokangtai Mono Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 166. Biokangtai Mono Vaccine Product and Services
Table 167. Biokangtai Mono Vaccine SWOT Analysis
Table 168. Biokangtai Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Mono Vaccine Distributors List
Table 172. Mono Vaccine Customers List
Table 173. Mono Vaccine Market Trends
Table 174. Mono Vaccine Market Drivers
Table 175. Mono Vaccine Market Challenges
Table 176. Mono Vaccine Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Mono Vaccine Product Picture
Figure 2. Global Mono Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Mono Vaccine Market Share by Type in 2022 & 2034
Figure 4. Meningococcal Vaccine Product Picture
Figure 5. Japanese Encephalitis Vaccine Product Picture
Figure 6. Yellow Fever Vaccine Product Picture
Figure 7. Hepatitis Vaccine Product Picture
Figure 8. Cholera Vaccine Product Picture
Figure 9. Other Product Picture
Figure 10. Global Mono Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 11. Global Mono Vaccine Market Share by Application in 2022 & 2034
Figure 12. Adults
Figure 13. Children
Figure 14. Mono Vaccine Report Years Considered
Figure 15. Global Mono Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Mono Vaccine Revenue 2018-2034 (US$ Million)
Figure 17. Global Mono Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Mono Vaccine Sales Quantity 2018-2034 (K Units)
Figure 19. Global Mono Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Mono Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Mono Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. North America Mono Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Mono Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. Europe Mono Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Mono Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. China Mono Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Mono Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. APAC Mono Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Mono Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Mono Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Mono Vaccine Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Mono Vaccine Revenue in 2022
Figure 33. Mono Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Mono Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Mono Vaccine Revenue Market Share by Type (2018-2034)
Figure 36. Global Mono Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Mono Vaccine Revenue Market Share by Application (2018-2034)
Figure 38. North America Mono Vaccine Revenue Market Share by Company in 2022
Figure 39. North America Mono Vaccine Sales Quantity Market Share by Company in 2022
Figure 40. North America Mono Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Mono Vaccine Revenue Market Share by Type (2018-2034)
Figure 42. North America Mono Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Mono Vaccine Revenue Market Share by Application (2018-2034)
Figure 44. North America Mono Vaccine Revenue Share by Country (2018-2034)
Figure 45. North America Mono Vaccine Sales Quantity Share by Country (2018-2034)
Figure 46. the United States Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Mono Vaccine Sales Quantity Market Share by Company in 2022
Figure 49. Europe Mono Vaccine Revenue Market Share by Company in 2022
Figure 50. Europe Mono Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Mono Vaccine Revenue Market Share by Type (2018-2034)
Figure 52. Europe Mono Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Mono Vaccine Revenue Market Share by Application (2018-2034)
Figure 54. Europe Mono Vaccine Revenue Share by Country (2018-2034)
Figure 55. Europe Mono Vaccine Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. France Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. UK Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 61. China Mono Vaccine Sales Quantity Market Share by Company in 2022
Figure 62. China Mono Vaccine Revenue Market Share by Company in 2022
Figure 63. China Mono Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Mono Vaccine Revenue Market Share by Type (2018-2034)
Figure 65. China Mono Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Mono Vaccine Revenue Market Share by Application (2018-2034)
Figure 67. APAC Mono Vaccine Sales Quantity Market Share by Company in 2022
Figure 68. APAC Mono Vaccine Revenue Market Share by Company in 2022
Figure 69. APAC Mono Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Mono Vaccine Revenue Market Share by Type (2018-2034)
Figure 71. APAC Mono Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Mono Vaccine Revenue Market Share by Application (2018-2034)
Figure 73. APAC Mono Vaccine Revenue Share by Region (2018-2034)
Figure 74. APAC Mono Vaccine Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 79. India Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Mono Vaccine Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Mono Vaccine Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Mono Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Mono Vaccine Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Mono Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Mono Vaccine Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Mono Vaccine Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Mono Vaccine Revenue Share by Country (2018-2034)
Figure 88. Brazil Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Mono Vaccine Revenue (2018-2034) & (US$ Million)
Figure 93. Mono Vaccine Value Chain
Figure 94. Mono Vaccine Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed